A trial of carbamazepine in borderline personality disorder

J M de la Fuente; F Lotstra

doi:10.1016/0924-977x(94)90296-8

A trial of carbamazepine in borderline personality disorder

Eur Neuropsychopharmacol. 1994 Dec;4(4):479-86. doi: 10.1016/0924-977x(94)90296-8.

Authors

J M de la Fuente¹, F Lotstra

Affiliation

¹ Department of Psychiatry, Erasme Hospital, Free University of Brussels (ULB), Belgium.

PMID: 7894258
DOI: 10.1016/0924-977x(94)90296-8

Abstract

Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Adult
Behavior
Borderline Personality Disorder / drug therapy*
Borderline Personality Disorder / psychology
Carbamazepine / therapeutic use*
Cross-Over Studies
Double-Blind Method
Female
Humans
Male
Middle Aged
Psychiatric Status Rating Scales

Substances

Carbamazepine